| | Canakinumab: Promising Drug Being Developed for Systemic JIA Results from two phase III trials, published in the New England Journal of Medicine, revealed that ACZ885 (canakinumab) significantly relieved symptoms in young patients with systemic juvenile idiopathic arthritis. The drug also delayed the recurrence of flares and allowed the SIJA patients to substantially reduce or discontinue the use of corticosteroids. Read more... | Arthritis Treatment Options An effective arthritis treatment regimen can help manage the disease. There are many treatment options which you should know about. Over time, you may try several different treatments and change your treatment plan. Read more... | Orencia - 10 Things You Should Know Orencia (abatacept) is a biologic drug used to treat moderate to severe rheumatoid arthritis in adults, and moderate to severe polyarticular juvenile idiopathic arthritis in children 6 years and older. Orencia is not a TNF blocker. Orencia is a T-cell co-stimulation modulator. Read more... | What Is C-Reactive Protein (CRP)? It is not a new test, but it is a test in the news. CRP, also known as C-Reactive Protein, is a test which measures the concentration in blood serum of a special type of protein produced in the liver that is present during episodes of acute inflammation or infection. Read more... | | | | Related Searches | | | | Featured Articles | | | | | | Sign up for more free newsletters on your favorite topics | | | | You are receiving this newsletter because you subscribed to the About.com Arthritis & Joint Conditions newsletter. If you wish to change your email address or unsubscribe, please click here. About.com respects your privacy: Our Privacy Policy Contact Information: 249 West 17th Street New York, NY, 10011 © 2012 About.com | | | | Must Reads | | | Follow me on: | | | | Advertisement | |
Nema komentara:
Objavi komentar